Cms formulary id: «cms_formulary_id»
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013
DRUG NAME
DILANTIN 50 MG ORAL CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW GENERIC EQUIVALENT. OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013
DRUG NAME
DUETACT 30 MG-2 MG ORAL CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW GENERIC EQUIVALENT. OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013
DRUG NAME
DUETACT 30 MG-4 MG ORAL CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW GENERIC EQUIVALENT. OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013
DRUG NAME
GRIS-PEG 250 MG ORAL CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW GENERIC EQUIVALENT. OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013
DRUG NAME
PROTONIX IV 40 MG INTRAVEN. CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW GENERIC EQUIVALENT. OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013
DRUG NAME
TRICOR 145MG ORAL CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW GENERIC EQUIVALENT. OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013
DRUG NAME
TRICOR 48 MG ORAL CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW GENERIC EQUIVALENT. OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013
DRUG NAME
ZERIT 1 MG/ML ORAL CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW GENERIC EQUIVALENT. OTHER POSSIBLE DRUGS
Source: https://www.alamedaalliance.org/~/media/files/modules/publications/pharmacy/2013%20acc%20pharmacy%20documents/future%20formulary%20change_june%202013.pdf
Deutscher Bundestag Drucksache 18/ […] 18. Wahlperiode der Abgeordneten Kordula Schulz-Asche, Ulle Schauws, Dr. Harald Terpe, Maria Klein-Schmeink, Elisabeth Scharfenberg, . und der Fraktion Bündnis 90/Die Grü- nen Selbstbestimmung bei der Notfallverhütung stärken - „Pille danach“ mit Wirkstoff Levonorgestrel schnell aus der Verschreibungspflicht entlassen Der Bun
CURRICULUM VITAE I. Personal data First name Initials Said Mohamed Surname name Date of birth Place of birth Nationality II. Academic degrees awarded - May 1995 - June 2003 Title: Feasibility study for large scale production of inulinase from local isolate. Key words: Aspergillus niger, factorial design, inulinase, Jerusalem artichoke, SDS-PAGE.
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z |
0-9 |